2021 marks a new era for Alzheimer's therapeutics

Lancet Neurol. 2022 Jan;21(1):3-4. doi: 10.1016/S1474-4422(21)00412-9.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Amyloid beta-Peptides
  • Humans

Substances

  • Amyloid beta-Peptides